Skip to main content
. 2019 Nov 15;5(4):2055217319888767. doi: 10.1177/2055217319888767

Figure 1.

Figure 1.

Faecalibacterium and alpha diversity in multiple sclerosis (MS) patients and healthy controls (HCs). (a) At baseline, MS patients had reduced levels of butyrate-producing Faecalibacterium compared to HCs. (b) No differences in alpha diversity measures of the Shannon index were observed. Mann-Whitney U-test, corrected with Benjamini Hochberg FDR.